Tracking fatigue and activity in lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study follows patients with advanced lung cancer to see how fatigue and physical activity change during treatment. It aims to help improve support for symptoms like tiredness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lung cancer that has spread or cannot be removed with surgery.
- You are 18 years or older.
- You are able to care for yourself and are not bedridden (ECOG score of 2 or less).
- You are about to start your first chemotherapy or immunotherapy treatment.
- You have no unstable heart disease or recent heart attack.
- You have no other cancer in the last 2 years (except for some skin or early-stage bladder or cervical cancers).
- You have no bone or muscle problems that prevent you from being active.
- You can speak and understand Dutch.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a coaching program to help you become more physically active after surgery for early-stage lung cancer. It may help you recover and improve your well-being.
This study tests whether cognitive behavioral therapy, a type of talking therapy, can help reduce severe fatigue in people with advanced solid tumors or gliomas who are receiving or have completed palliative treatment. The goal is to see if this approach improves energy levels and quality of life.
This study looks at why cancer can cause loss of muscle in people with advanced non–small cell lung cancer, and whether exercise can improve or explain those muscle changes. You may be asked to do physical testing and answer questionnaires while receiving standard palliative cancer treatment.
This study aims to understand how maintenance immunotherapy affects fatigue in people with non-small cell lung cancer. Researchers will talk with patients to learn about their experiences.
This study looks at how lung cancer treatment affects the heart and whether a “walking test” and blood tests can track heart fitness and injury. It may help by improving how cancer therapy is planned and monitored for heart safety.
This trial tests whether using a web-based tool to track symptoms can help people with advanced lung cancer live longer and feel better. You would report symptoms regularly, and your care team would use that information to adjust your care.
Hear when a new Lung Cancer (Locally Advanced or Metastatic) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.